DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Charles-Schoeman C. et al.
Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis.
Arthritis Rheumatol 2019;
71: 1450-1459 doi:10.1002/art.40911
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.